注射器市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00003521
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Syringes Market Analysis 2021-2031 | Trends and Top Players

Buy Now

2021 年注射器市场规模为 152.7 亿美元,预计到 2031 年将达到 377.2 亿美元。预计 2023-2031 年市场复合年增长率为 9.4%。对预充式注射器系统和自动注射器的日益增长的倾向可能仍是注射器市场的主要趋势。

注射器市场分析

医疗保健行业的扩张、慢性病和传染病发病率的上升、全球疫苗接种率的提高、由于注射速度更快而受到越来越多的青睐以及一次性注射器的日益普及是支持注射器市场增长的一些主要因素。注射器现在经常用于临床研究实验室、药品制造和医院。它们越来越多地被用于输送各种医疗保健药物和提取研究或疾病诊断所需的体液。此外,蓬勃发展的胰岛素注射器行业和新兴国家预充式注射器市场渗透率的不断提高也对医用注射器的销售产生了积极影响。因此,传染病和慢性病发病率的上升可能会在预测期内继续推动注射器的销售。

注射器市场概况

注射器是一种活塞状的医疗器械,在医疗保健中具有重要意义。注射器在营养补充剂、疫苗和药物的管理中起着重要作用。该产品具有广泛的适用性,从将液体营养物质注入喂食管到进行疫苗接种。美国医疗保健系统见证了对新产品推出的大量投资。此外,大多数参与者都从事产品创新、销售和研究合作以及产品批准等业务活动。此外,癌症是全球巨大的医疗保健负担。根据疾病控制和预防中心的数据,2020 年美国诊断出约 1,603,844 例新癌症病例,癌症死亡人数为 602,347 人。每 100,000 人中,报告了 403 例新癌症病例。此外,根据国际癌症研究机构的数据,到 2040 年,新癌症病例预计将达到 3020 万。注射器在癌症治疗的许多阶段都有使用,所有这些因素都可能在预测期内加速市场增长。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

注射器市场:

注射器市场
  • Syringes Market
    复合年增长率(2023 - 2031)
    9.4%
  • 2021 年市场规模
    152.7 亿美元
  • 2031年市场规模
    377.2亿美元

市场动态

增长动力
  • 慢性病和传染病数量不断增加
  • 注射药物的使用率不断提高
未来的趋势
  • 预充式注射器系统日益受到青睐
机会
  • 市场参与者推出的产品

关键人物;主力;重要一员

  • 屋宇署
  • 百特国际公司
  • 泰尔茂株式会社
  • 维塔针业公司
  • 康德乐公司
  • 尼普罗
  • 可伸缩技术公司
  • B. Braun Melsungen AG
  • AIR-TITE 产品有限公司
  • 亨克·萨斯,沃尔夫

区域概况

Syringes Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Syringes Market注射器类型
  • 鲁尔锁注射器
  • 玻璃注射器
  • 鲁尔滑接头注射器
  • 其他的
Syringes Market应用
  • 美学
  • 人类健康
  • 实验室/工业应用
  • 其他应用
Syringes Market可用性
  • 可灭菌/可重复使用注射器
  • 一次性注射器
Syringes Market最终用户
  • 医院和诊所
  • 血液采集中心
  • 糖尿病护理中心
  • 其他最终用户
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

注射器市场驱动因素和机遇

慢性病和传染病数量增加推动市场增长

慢性疾病包括心血管疾病、糖尿病和癌症,是成年人死亡的主要原因。传染病也是儿童和成年人死亡的主要原因。在全球范围内,大约三分之一的成年人患有多种慢性病。在美国,十分之六的成年人患有慢性病,十分之四的成年人患有两种或两种以上的慢性病。慢性病和传染病需要使用各种需要使用注射器的医学测试进行持续诊断。人口老龄化加剧以及社会行为和生活方式的变化导致了一些常见的长期健康状况。根据世界卫生组织的数据,到 2026 年底,慢性生活方式疾病的患病率预计将增加 57%。糖尿病是 21 世纪全球主要的健康问题之一。根据国际糖尿病联合会的数据,2021 年全球约有 5.37 亿人患有糖尿病,预计到 2045 年全球糖尿病患者人数将达到 7.38 亿。根据美国疾病控制与预防中心的报告,超过 3700 万美国人(约占十分之一)患有糖尿病,其中近 90-95% 患有 2 型糖尿病。注射药物在治疗慢性病和传染病方面的应用日益广泛,预计将推动注射器的需求和采用,从而推动市场增长。

市场参与者推出的产品有利于市场增长

各种市场参与者都专注于产品发布或战略合作,以开发有助于轻松治疗慢性疾病的先进产品。近年来,出现了各种发展,例如产品发布、合并和收购。下面提到了其中一些:

2022 年 10 月,Terumo Corporation 旗下的 Terumo Pharmaceutical Solutions 推出了一款即装型聚合物注射器,用于容量较大的具有挑战性的生物技术药物。带锥形针的 PLAJEX 2.25 mL 专为满足生物技术市场而设计,使其适用于复杂的药物应用,例如高粘度生物技术药物。

2022 年 9 月,Becton, Dickinson and Company 推出了新一代玻璃预灌封注射器,该注射器以新的更严格的规格为疫苗预灌封注射器树立了新的性能标准。新型 BD effivax 玻璃预灌封注射器是与知名制药公司合作设计的,旨在满足疫苗制造复杂且不断发展的需求。

因此,产品上市数量的激增可能会为未来注射器市场创造相当大的增长机会。

注射器市场报告细分分析

有助于注射器市场分析的关键部分是成分类型、形式和适应症。

  • 根据注射器类型,注射器市场分为鲁尔锁注射器、玻璃注射器、鲁尔滑套注射器等。鲁尔锁注射器部分在 2023 年占据最大的市场份额。此外,预计玻璃注射器部分在预测期内的复合年增长率最高。
  • 根据应用,市场分为美学、人类健康、实验室/工业应用、其他应用。2023 年,人类健康领域占据了最大的市场份额。此外,预计美学领域在预测期内的复合年增长率最高。
  • 就可用性而言,市场分为可灭菌/可重复使用注射器和一次性注射器。一次性注射器部分在 2023 年占据最大的市场份额,预计在预测期内将实现最高的复合年增长率。
  • 根据最终用户,注射器市场分为医院和诊所、血液采集中心、糖尿病护理中心和其他最终用户。医院和诊所部分在 2023 年占据最大的市场份额。此外,糖尿病护理中心部分预计在预测期内实现最高复合年增长率。

注射器市场份额按地区分析

注射器市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。

北美主导了注射器市场。北美市场正在扩大,原因有很多,包括慢性病和生活方式疾病的患病率上升、产品批准的增加、对专用注射器的认识提高、注射设备的进步以及生物制剂的批准增加。West Pharmaceutical Services, Inc. 是一家生产注射药物管理创新解决方案的公司,该公司在 2022 年 6 月的 BIO 国际大会上展示了其新的预灌封 Daikyo Crystal Zenith 2.25mL 插入针注射器系统。Daikyo Crystal Zenith 是一种技术先进的环烯烃聚合物容器和输送系统,可替代玻璃,降低破损风险并降低颗粒、污染和可萃取物的可能性。

预计亚太地区将在未来几年以最高的复合年增长率增长。技术进步日新月异、人口迅速老龄化、国际参与者对该地区日益关注、快速城市化以及对新型注射剂审批的支持性监管框架正在支持该地区市场的增长。

注射器市场报告范围

报告属性细节
2021 年市场规模152.7亿美元
2031 年市场规模377.2亿美元
全球复合年增长率(2023 - 2031)9.4%
历史数据2021-2022
预测期2024-2031
涵盖的领域按注射器类型
  • 鲁尔锁注射器
  • 玻璃注射器
  • 鲁尔滑接头注射器
  • 其他的
按应用
  • 美学
  • 人类健康
  • 实验室/工业应用
  • 其他应用
按可用性
  • 可灭菌/可重复使用注射器
  • 一次性注射器
按最终用户
  • 医院和诊所
  • 血液采集中心
  • 糖尿病护理中心
  • 其他最终用户
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 屋宇署
  • 百特国际公司
  • 泰尔茂株式会社
  • 维塔针业公司
  • 康德乐公司
  • 尼普罗
  • 可伸缩技术公司
  • B. Braun Melsungen AG
  • AIR-TITE 产品有限公司
  • 亨克·萨斯,沃尔夫
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

注射器市场新闻和最新发展

注射器市场通过收集主要和次要研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是注射器市场的发展和策略列表:

  • 2023 年 11 月,Terumo Corporation 的印度分公司 Terumo India 推出了胰岛素注射器,这是一种无菌输送装置,适用于需要定期注射胰岛素的患者,从而提高了患者的舒适度和治疗依从性。这些注射器以及该公司的 Pen 针头 - FineGlide 也可作为独立产品在印度所有主要药店购买。(来源:Terumo Corporation,新闻稿,2023 年)
  • 2022 年 1 月,ICU Medical Inc. 完成了对 Smiths Group plc 旗下 Smiths Medical 的收购。Smiths Medical 的业务(包括注射器和便携式输液设备、血管通路和重要护理产品)加入 ICU Medical 产品组合,打造出一家全球影响力更强大的领先输液治疗公司。(来源:ICU Medical,新闻稿,2022 年)

注射器市场报告覆盖范围和交付成果

“注射器市场规模和预测(2021-2031)”报告对市场进行了详细的分析,涵盖以下领域:

  • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..